Genetic variants and risk of thyroid cancer among Iranian patients.

The definition of an exclusive panel of genetic markers is of high importance to initially detect among this review population. Therefore, we gave a summary of each main genetic marker among Iranian patients with thyroid cancer for the first time which were classified based on their cellular function. Due to the results, a significant relationship was found between SNP in codons 194, 280, and 399 (C1), Allele 3434Thr (C7), GC or CC genotype 31, G/C (Survivin), 399G>A (C1), 9I (vitamin D receptor), G-D haplotype (2), TT genotype, -656 G/T (18), TAGTT haplotype (18), G allele in +49 A>G (A-4), +7146 G/A (1.3), +7785 C/T (1.5), rs1143770 (7a-2), rs4938723 (-mir-34b/c) genes, and thyroid cancers. Moreover, SNP in 677C-->T (FR), GG genotype Asp1312Gly (thyroglobulin), 2259C>T (52), R188H, (C2), T241M (C3) had higher risks of thyroid cancer and lower risks were observed in -16 Ins-Pro (), rs3742330 (ER1). At last, the protective effects were explored in 127 CC genotype (18), rs6877842 (SHA). Conduct further studies on the types of DNA repair gene polymorphisms with a larger number in the thyroid cancer using modern methods such as SNP array so that these genes could be used as a biomarker in prediction, diagnosis, and treatment of thyroid cancer. This review presents for the first time a summary of important genetic markers in Iranian patients with thyroid cancer.